JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

ST-segment elevation myocardial infarction

B Vogel, BE Claessen, SV Arnold, D Chan… - Nature reviews Disease …, 2019 - nature.com
ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

Acute myocardial infarction

GW Reed, JE Rossi, CP Cannon - The Lancet, 2017 - thelancet.com
Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …

Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from …

S Bangalore, S Kumar, M Fusaro, N Amoroso… - Circulation, 2012 - Am Heart Assoc
Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade;
however, the relative short-and long-term efficacy and safety of DES compared with bare …

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation …

Authors/Task Force Members… - European heart …, 2008 - academic.oup.com
Document Reviewers: Sigmund Silber (CPG Review Coordinator)(Germany), Frank V.
Aguirre (USA), Nawwar Al-Attar (France), Eduardo Alegria (Spain), Felicita Andreotti (Italy) …

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

M Sabate, A Cequier, A Iñiguez, A Serra… - The Lancet, 2012 - thelancet.com
Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective
percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind …

G Montalescot, SD Wiviott, E Braunwald, SA Murphy… - The Lancet, 2009 - thelancet.com
Background Mechanical reperfusion with stenting for ST-elevation myocardial infarction
(STEMI) is supported by dual antiplatelet treatment with aspirin and clopidogrel. Prasugrel, a …

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

C Stettler, S Wandel, S Allemann, A Kastrati… - The Lancet, 2007 - thelancet.com
Background Whether the two drug-eluting stents approved by the US Food and Drug
Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …

Coronary stents: current status

S Garg, PW Serruys - Journal of the American College of Cardiology, 2010 - jacc.org
Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

2007 focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American …

SB King III, SC Smith Jr, JW Hirshfeld Jr, AK Jacobs… - Circulation, 2008 - Am Heart Assoc
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. acc. org), American Heart Association (my …